Order Profhilo® H+L 2mL Online for Clinics

Profhilo® H+L is a sterile hyaluronic acid injectable supplied as a 2 mL prefilled syringe for professional aesthetic use. Licensed clinics, med spas, and healthcare professionals use this Profhilo H+L 2ml format within skin-quality protocols where sterile handling, predictable room setup, and accurate documentation matter. The presentation includes a prefilled syringe and accessory needles to support efficient treatment-room preparation.

Med Wholesale Supplies serves professional accounts with brand-name medical products sourced through vetted distributors and verified supply channels. Profhilo® H+L is intended for trained injectors working under facility protocols, not for unsupervised consumer use. Current account pricing, lot availability, and ordering details can be viewed after clinic account access is established.

Profhilo® H+L Price and Clinic Ordering

Clinics evaluating Profhilo H+L price should consider the full unit presentation rather than only the syringe volume. This product is supplied as 1 × 2 mL prefilled syringe with two sterile 29G × 1/2 needles, which can reduce separate accessory selection and simplify procedure-cart preparation. Account-level pricing may vary based on current supply, order volume, and purchasing arrangements.

Professional buyers can order Profhilo H+L online for clinic inventory planning, scheduled skin-booster sessions, and broader aesthetic service lines. Because this is a B2B clinic supply item, documentation, staff credentials, and account verification may apply before purchasing features are available. For related professional injectable categories, teams can browse skin boosters and mesotherapy supplies when coordinating adjacent treatment-room stock.

Quick tip: Match reorder quantities to planned chair time, maintenance visits, and the clinic’s documentation process for lot and expiry tracking.

What Profhilo® H+L Is

Profhilo® H+L is a stabilized hyaluronic acid preparation designed for professional intradermal or superficial soft-tissue aesthetic workflows. The H+L designation refers to a balanced profile of high- and low-molecular-weight sodium hyaluronate. This composition is commonly discussed as a bio-remodeling or injectable skin-booster platform because it supports broad skin-quality goals rather than focal contour correction.

Hyaluronic acid is a naturally occurring glycosaminoglycan that binds water and contributes to tissue hydration. In aesthetic practice, HA-based injectables are selected according to their formulation, rheology, intended tissue plane, and treatment objective. Profhilo® H+L is stabilized without BDDE chemical cross-linking; the existing product information describes thermal processing and purification that support reliable handling and biocompatibility.

The formulation disperses efficiently in superficial planes when used by trained injectors following appropriate technique. Clinics often position this class differently from volumizing fillers: the goal is typically hydration, elasticity support, and improvement in overall skin texture, not a sharply defined lift or projection. For a broader discussion of HA materials in wrinkle and skin-quality programs, see collagen and hyaluronic acid considerations.

Professional Applications and Protocol Fit

Clinicians incorporate Profhilo® H+L into aesthetic programs focused on skin quality, laxity appearance, hydration support, and more uniform texture. Commonly assessed facial areas include malar, submalar, and malar-zygomatic zones, with additional sites determined by injector training, anatomy, and clinic protocol. Use should be limited to healthcare professionals experienced with injectable techniques and patient assessment.

A typical initiation approach described in aesthetic practice involves two sessions spaced about 30 days apart, followed by maintenance planning at the provider’s discretion. Individual protocols may vary by treatment area, skin quality, prior procedures, and patient-specific risk factors. Clinics may integrate Profhilo® H+L into stand-alone skin-booster programs or sequence it around other aesthetic services when medically appropriate.

Because the product is not positioned as a conventional filling gel for precise volumization, it can complement rather than replace contouring products. Treatment planning should distinguish between hydration and skin-quality support, dynamic wrinkle management, structural volume replacement, and resurfacing goals. For service design ideas centered on hydration and elasticity, review Profhilo injection workflow concepts and skin elasticity assessment planning.

Composition, Strength, and Pack Details

Profhilo® H+L is supplied as a sterile prefilled syringe containing 2 mL. The current product title identifies the format as Profhilo H+L 32mg 1 × 2mL prefilled syringe, supporting straightforward inventory recognition for clinics that manage multiple HA products. The single-use presentation helps teams document which unit was assigned to a procedure and reduces manual preparation steps.

The prefilled syringe presentation supports back-to-back appointments because staff can prepare the treatment room without drawing product from a vial. Lot number and expiration details should be recorded according to the clinic’s medical record and inventory SOPs. For additional items in the same brand family, visit the Profhilo brand selection.

Handling, Storage, and Documentation

Store and handle Profhilo® H+L according to manufacturer instructions and your facility’s sterile product procedures. The syringe is intended for single-patient use, and sterile accessories should remain in intact packaging until preparation for administration. Staff should inspect packaging, confirm the lot and expiry, and document the product used before completing the procedure record.

Clinic teams should maintain separation between intake stock, opened procedure supplies, and disposed sharps or biohazard materials. The included 29G needles support standardization, but injector preference and protocol requirements should still guide final setup. Temperature-controlled handling when required and tracked US delivery may be used as part of logistics planning for professional accounts.

Why it matters: Consistent documentation supports traceability, recall response, and internal quality review.

Safety, Contraindications, and Injector Assessment

Profhilo® H+L should be administered only by appropriately trained healthcare professionals. As with other injectable HA products, treatment planning should include medical history review, skin assessment, prior aesthetic procedures, allergy history, active infection screening, and anatomic risk evaluation. Do not inject through inflamed, infected, or compromised skin, and follow all aseptic technique requirements.

Expected local reactions can include injection-site redness, swelling, bruising, tenderness, itching, or transient nodules. More serious but less common injection-related risks may include infection, inflammatory reactions, vascular compromise, tissue injury, or persistent nodularity. Clinics should maintain protocols for post-procedure instructions, adverse-event documentation, and escalation when symptoms suggest infection, vascular symptoms, visual disturbance, severe pain, or unexpected tissue change.

Patient selection remains central to safe use. Caution is appropriate for individuals with a history of severe allergy, autoimmune or inflammatory skin conditions, bleeding risk, anticoagulant use, recent procedures in the treatment area, or unrealistic expectations. For practical discussion of unwanted outcomes and risk mitigation, see potential Profhilo side effects. This internal material supports clinic discussion but does not replace product labeling, professional training, or medical judgment.

How It Compares With Related Skin-Quality Injectables

Profhilo® H+L is often compared with other HA-based skin boosters and biostimulatory-adjacent aesthetic products because the clinical goal may overlap: improved hydration, surface quality, and skin firmness appearance. The main practical distinctions for clinics are formulation, intended injection plane, syringe volume, accessories, training requirements, and how each product fits with fillers, neuromodulators, resurfacing, or regenerative protocols.

For practices building a skin-quality menu, the Profhilo range may be considered alongside body-focused or structure-oriented presentations when appropriate. Related products include Profhilo Body Kit for body programs and Profhilo Structura when a clinic is evaluating other Profhilo portfolio items. Selection should be based on provider assessment, training, treatment area, and the outcome category being addressed.

Clinics may also evaluate other skin-booster brands for hydration and texture workflows. Jalupro Super Hydro, Sunekos, and Viscoderm Hydrobooster are examples of adjacent products that may be mapped to different protocols. For side-by-side clinical decision factors, see Jalupro and Profhilo comparison considerations.

Procurement Planning for Aesthetic Practices

Clinic purchasing teams should align Profhilo® H+L procurement with appointment volume, injector schedules, and the number of sessions planned per treatment series. Because each syringe is single use, inventory forecasting should account for initiation sessions, maintenance visits, cancellations, and buffer stock policies. Product rotation by expiration date helps reduce avoidable waste.

Operationally, Profhilo® H+L fits practices that want a defined syringe format, included accessory needles, and clear lot documentation. It may be stocked with other HA skin boosters, mesotherapy items, and procedure-room consumables so staff can prepare consistent trays. Teams adding the service for the first time should also plan staff training, consent language, photography workflows, adverse-event escalation steps, and aftercare instructions.

Current account pricing and ordering tools help facilities consolidate purchasing cycles across related injectables and aesthetic supplies. Clinics with multiple service lines may review broader skin-booster injection categories before deciding how Profhilo® H+L will sit within a treatment menu.

Availability, US Distribution, and Substitutions

Profhilo® H+L is available through US distribution for licensed professional accounts. Supply can vary by lot intake and purchasing demand, so teams should avoid waiting until the final scheduled syringe is used before reordering. Lot and expiry information should be reconciled when inventory arrives and again when units are assigned to procedures.

If a preferred unit is temporarily constrained, a clinic representative may help identify an appropriate same-class or adjacent product for procurement planning. Substitutions should not be treated as automatic clinical equivalents; formulation, training, technique, and treatment goals must be reviewed by the provider before a different product is used. Body-focused plans, for example, may require a different Profhilo presentation than a facial skin-quality series.

Authoritative Sources

• Official Profhilo manufacturer information
• American Society of Plastic Surgeons dermal filler safety context

This content is for informational purposes only and is not a substitute for professional medical advice.